Evidence map›Paper›PMID 27302191›Full record

ArticleThe Journal of infectious diseases2016

Epidemiology of a Novel Recombinant Middle East Respiratory Syndrome Coronavirus in Humans in Saudi Arabia.

Abdullah M Assiri, Claire M Midgley, Glen R Abedi, Abdulaziz Bin Saeed, Malak M Almasri, Xiaoyan Lu, Hail M Al-Abdely, Osman Abdalla, Mutaz Mohammed, Homoud S Algarni and 18 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetic diversity of MERS-CoV spike protein gene in Saudi Arabia.Journal of infection and public health · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 4 institutions in 2 countries.

Abdullah M AssiriMinistry of Health.
Claire M MidgleyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Glen R AbediDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Abdulaziz Bin SaeedMinistry of Health Department of Family and Community Medicine, King Saud Medical City.
Malak M AlmasriMinistry of Health.
Xiaoyan LuDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Hail M Al-AbdelyMinistry of Health.
Osman AbdallaMinistry of Health.
Mutaz MohammedMinistry of Health.
Homoud S AlgarniMinistry of Health.
Raafat F AlhakeemMinistry of Health.
Senthilkumar K SakthivelDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Randa NoohMinistry of Health Field Epidemiology Training Program, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Zainab AlshayabMinistry of Health Field Epidemiology Training Program, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Mohammad AlessaMinistry of Health Field Epidemiology Training Program, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Ganesh SrinivasamoorthyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Saeed Yahya AlQahtaniMinistry of Health.
Ali KheyamiMinistry of Health.
Waleed Husein HajOmarMinistry of Health.
Talib M BanaserMinistry of Health.
Ahmad EsmaeelMinistry of Health.
Aron J HallDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Aaron T CurnsDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Azaibi TaminDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Ali Abraheem AlsharefMinistry of Health.
Dean ErdmanDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
John T WatsonDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases.
National Center for Immunization and Respiratory Diseases · USMinistry of Health · SAEpidemic Intelligence Service · USKing Saud Medical City · SA

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory illness in humans. Fundamental questions about circulating viruses and transmission routes remain.

methodsWe assessed routinely collected epidemiologic data for MERS-CoV cases reported in Saudi Arabia during 1 January-30 June 2015 and conducted a more detailed investigation of cases reported during February 2015. Available respiratory specimens were obtained for sequencing.

resultsDuring the study period, 216 MERS-CoV cases were reported. Full genome (n = 17) or spike gene sequences (n = 82) were obtained from 99 individuals. Most sequences (72 of 99 [73%]) formed a discrete, novel recombinant subclade (NRC-2015), which was detected in 6 regions and became predominant by June 2015. No clinical differences were noted between clades. Among 87 cases reported during February 2015, 13 had no recognized risks for secondary acquisition; 12 of these 13 also denied camel contact. Most viruses (8 of 9) from these 13 individuals belonged to NRC-2015. DISCUSSIONS: Our findings document the spread and eventual predominance of NRC-2015 in humans in Saudi Arabia during the first half of 2015. Our identification of cases without recognized risk factors but with similar virus sequences indicates the need for better understanding of risk factors for MERS-CoV transmission.

Indexed as

AdultAgedAged, 80 and overCluster AnalysisCoronavirus InfectionsFemaleHumansMaleMiddle AgedMiddle East Respiratory Syndrome CoronavirusMolecular EpidemiologyPhylogenySaudi ArabiaSequence Analysis, DNASequence HomologySpike Glycoprotein, CoronavirusSpike Glycoprotein, CoronaviruscoronavirusMERSMERS epidemiologyMERS phylogenyMERS transmissionMiddle East respiratory syndromerecombinantSaudi Arabia

Identifiers

PMID27302191
PMCPMC5712457
OpenAlexW2465975956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.